NASDAQ: AQST
Aquestive Therapeutics Inc Stock Ownership - Who owns Aquestive Therapeutics?

Insider buying vs selling

Have Aquestive Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Daniel BarberCEO;Pres2026-07-1620,369$4.00
$81.52kSell
Daniel BarberCEO;Pres2026-07-154,631$4.03
$18.68kSell
Julie KropDirector2026-06-2325,000$0.71
$17.83kBuy
Julie KropDirector2026-06-2325,000$5.02
$125.40kSell
Daniel BarberPresident and CEO2026-06-1525,000$4.16
$104.00kSell
Daniel BarberPresident and CEO2026-05-158,257$4.29
$35.41kSell
Melina CioffiSVP Regulatory Affairs2026-05-151,667$4.17
$6.95kSell
Lori J. BraenderCorporate Secretary2026-05-07135,690$4.23
$573.97kSell
Cassie JungChief Operating Officer2026-05-0572,734$4.18
$304.03kSell
A. Ernest Toth Jr.Chief Financial Officer2026-05-0592,652$4.18
$387.29kSell

1 of 4

AQST insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when AQST insiders and whales buy or sell their stock.

AQST Shareholders

What type of owners hold Aquestive Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bratton Capital Management LP7.82%9,810,958$36.89MInstitution
Blackrock Inc5.99%7,509,071$28.23MInstitution
Rtw Investments LP5.92%7,426,471$27.92MInstitution
Vanguard Capital Management LLC3.54%4,443,698$16.71MInstitution
Federated Hermes Inc2.34%2,940,339$11.06MInstitution
Balyasny Asset Management LP2.31%2,900,570$10.91MInstitution
State Street Corp2.03%2,546,191$9.57MInstitution
Samsara Biocapital LLC1.99%2,500,000$9.40MInstitution
Geode Capital Management LLC1.92%2,408,191$9.05MInstitution
Bank Of America Corp1.92%2,405,050$9.04MInstitution

1 of 3

AQST vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AQST57.21%5.89%Net SellingNet Selling
KMDA8.89%45.48%
EOLS69.33%28.02%Net Selling
EBS46.12%53.88%Net SellingNet Selling
CGC6.95%26.03%Net SellingNet Selling

Aquestive Therapeutics Stock Ownership FAQ

Who owns Aquestive Therapeutics?

Aquestive Therapeutics (NASDAQ: AQST) is owned by 57.21% institutional shareholders, 5.89% Aquestive Therapeutics insiders, and 36.90% retail investors. Douglas K. Bratton is the largest individual Aquestive Therapeutics shareholder, owning 1.96M shares representing 1.57% of the company. Douglas K. Bratton's Aquestive Therapeutics shares are currently valued at $7.07M.

If you're new to stock investing, here's how to buy Aquestive Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.